Back
Aytu BioPharma Vs. NeuroBo Pharmaceuticals Industry Stock Comparison
Sell
40
AYTU
Aytu BioPharma
Last Price:
2.35
Seasonality Move:
78.97%
Sell
26
NRBO
NeuroBo Pharmaceuticals
Last Price:
3.25
Seasonality Move:
-38.71%
Sell
40
Aytu BioPharma (AYTU)
is a Sell
Is Aytu BioPharma a Buy, Sell or Hold?
- The current Aytu BioPharma [AYTU] share price is $2.36. The Score for AYTU is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- AYTU is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Is NeuroBo Pharmaceuticals a Buy, Sell or Hold?
- The current NeuroBo Pharmaceuticals [NRBO] share price is $3.32. The Score for NRBO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- NRBO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AYTU Stock Price Chart
What is Aytu BioPharma's stock price today?
-
The Aytu BioPharma share price today is $2.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AYTU is experiencing selling pressure, which indicates risk of future bearish movement.
NRBO Stock Price Chart
What is NeuroBo Pharmaceuticals's stock price today?
-
The NeuroBo Pharmaceuticals share price today is $3.32
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing buying pressure, which is a positive indicator for future bullish movement.
AYTU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 44.62 | Sell |
Chaikin Money Flow: | -136218 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.37 - 2.57) | Sell |
Bollinger Bands (100): | (2.48 - 3.04) | Sell |
NRBO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 42.81 | Sell |
Chaikin Money Flow: | 30825 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.26 - 3.68) | Sell |
Bollinger Bands (100): | (3.54 - 4.44) | Sell |
AYTU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.47 | Sell |
20-day SMA: | 2.48 | Sell |
50-day SMA: | 2.53 | Sell |
200-day SMA: | 2.83 | Sell |
8-day EMA: | 2.5 | Sell |
20-day EMA: | 2.49 | Sell |
50-day EMA: | 2.56 | Sell |
200-day EMA: | 2.83 | Sell |
NRBO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.28 | Buy |
20-day SMA: | 3.48 | Sell |
50-day SMA: | 3.7 | Sell |
200-day SMA: | 4.05 | Sell |
8-day EMA: | 3.33 | Sell |
20-day EMA: | 3.44 | Sell |
50-day EMA: | 3.67 | Sell |
200-day EMA: | 5.68 | Sell |
Aytu BioPharma Earnings Growth & AYTU Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.44 per share, and a decrease next year of $0.00 per share.
NeuroBo Pharmaceuticals Earnings Growth & NRBO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aytu BioPharma Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NeuroBo Pharmaceuticals Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |